Organization
Vectura Group Plc
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Vectura Group Plc
... Chippenham, UK - Vectura Group plc (LSE: VEC) ('Vectura', 'the Group'), announces that the Board has approved a ...
... Those waiting for Hikma and Vectura’s copy of GlaxoSmithKline blockbuster Advair may be waiting awhile. After receiving a ...
... we made significant progress with our clinical stage programs. We partnered with Vectura to develop Pulmatrix's drug candidate, PUR0200, for chronic obstructive pulmonary disease (COPD) ...
... Previously, she was CFO of BBI Diagnostics Group Ltd and FTSE-listed Vectura Group plc. Prior to her role at Vectura, Anne held a number of ...
... FTSE 250 inhaler maker Vectura enjoyed a lift yesterday after its improved version of asthma medicine Flutiform ...
... huge impact on a person's quality of life and day-to-day activities. About Vectura Vectura, a FTSE250 company listed on the London Stock Exchange (LSE: VEC), ...
... SHARES in inhaler maker Vectura dropped as much as 14 per cent yesterday after the firm reported ...
... SHARES in FTSE 250 inhaler maker Vectura fell 12.9pc yesterday as the firm posted increased half-year losses. The group, ...
... pulmonary diseases, today announced that it has partnered withVecturaGroup plc (LSE: VEC) ("Vectura") to develop Pulmatrix's drug candidate, PUR0200, for chronic obstructive pulmonary disease (COPD) ...
... Chippenham, UK - Vectura Group plc (LSE: VEC) ('Vectura', 'the Group'), an industry leading device and formulation business ...
... Chippenham, UK - Vectura Group plc (LSE: VEC) ('Vectura'), an industry-leading device and formulation business for inhaled airways ...
... put together a €20 million financing round by July 2018. Statement > Vectura landed a deal with Dynavax. The agreement clears Dynavax to use Vectura’s ...
... VECTURA, the FTSE 250 maker of respiratory devices, yesterday announced an exclusive agreement ...
... sector. For more information about this report visit - Zelos Therapeutics - Vectura - United Therapeutics - UCB - Tianjin Kinnovata Pharmaceutial - Teva - ...
... Chippenham, UK - Vectura Group plc (LSE: VEC) ('Vectura', 'the Group'), an industry-leading device and formulation business for ...
... Vectura Group plc along with its co-development partner UCB SA has announced that they ...
... Chippenham, UK - Vectura Group plc (LSE: VEC) ('the Group'), an industry-leading inhaled airways disease focused business, will ...
... while the inhaler device is to come from British device maker Vectura Group Plc. "Given the nature of the (FDA) feedback, Hikma believes there is ...
... Chippenham, UK - Vectura Group plc (LSE: VEC) ('Vectura'), an industry-leading device and formulation business for inhaled airways ...
... downgraded National Grid to "hold". Other laggards included pharma stocks Hikma and Vectura, which spent a second consecutive trading session in the doldrums. Speculation US ...
... Berenberg remained negative on the FTSE 100 stock. Pharma stocks Hikma and Vectura came under pressure in afternoon trade amid speculation US regulators will not ...
... Vectura Group plc Launch of UtibronTM Neohaler® in the US Chippenham, UK - 3 ...
... Respiratory specialist Vectura has ended what was a transformational year for the business on a ...
... Board as Chief Operations Officer and President of US Operations of Vectura Group plc (the 'Company') at the AGM on 25 May 2017 and will ...
... Vectura Group plc (LSE: VEC) ('Vectura', 'the Group', 'the Company'), an industry-leading device and formulation ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤